Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel NHEJ1 pathogenic variant linked to severe combined immunodeficiency, microcephaly, and abnormal T and B cell receptor repertoires. | Front Pediatr | 2022 | 35967585 | PubTator, text mining | PubMed |
| Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review. | Front Oncol | 2022 | 35936676 | PubTator, text mining | PubMed |
| Human Variation in DNA Repair, Immune Function, and Cancer Risk. | Front Immunol | 2022 | 35935942 | PubTator, text mining | PubMed |
| Case Report: Prenatal Identification of a De Novo Mosaic Neocentric Marker Resulting in 13q31.1→qter Tetrasomy in a Mildly Affected Girl. | Front Genet | 2022 | 35928455 | PubTator, text mining | PubMed |
| Genetic associations with healthy ageing among Chinese adults. | NPJ Aging | 2022 | 35927272 | PubTator, text mining | PubMed |
| To indel or not to indel: Factors influencing mutagenesis during chromosomal break end joining. | DNA Repair (Amst) | 2022 | 35926296 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated epigenetic editing tool: An optimized strategy for targeting de novo DNA methylation with stable status via homology directed repair pathway. | Biochimie | 2022 | 35921985 | PubTator, text mining | PubMed |
| Novel CRISPR/Cas9-mediated knockout of LIG4 increases efficiency of site-specific integration in Chinese hamster ovary cell line. | Biotechnol Lett | 2022 | 35918621 | PubTator, text mining | PubMed |
| Target residence of Cas9-sgRNA influences DNA double-strand break repair pathway choices in CRISPR/Cas9 genome editing. | Genome Biol | 2022 | 35915475 | PubTator, text mining | PubMed |
| Chromatin and the Cellular Response to Particle Radiation-Induced Oxidative and Clustered DNA Damage. | Front Cell Dev Biol | 2022 | 35912116 | PubTator, text mining | PubMed |
| Strategies to improve homology-based repair outcomes following CRISPR-based gene editing in mosquitoes: lessons in how to keep any repair disruptions local. | Virol J | 2022 | 35908059 | PubTator, text mining | PubMed |
| Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy. | Molecules | 2022 | 35897913 | PubTator, text mining | PubMed |
| Chaperoning of the histone octamer by the acidic domain of DNA repair factor APLF. | Sci Adv | 2022 | 35895815 | PubTator, text mining | PubMed |
| Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation. | J Clin Med | 2022 | 35887984 | PubTator, text mining | PubMed |
| ATR Contributes More Than ATM in Intra-S-Phase Checkpoint Activation after IR, and DNA-PKcs Facilitates Recovery: Evidence for Modular Integration of ATM/ATR/DNA-PKcs Functions. | Int J Mol Sci | 2022 | 35886852 | PubTator, text mining | PubMed |
| P63 and P73 Activation in Cancers with p53 Mutation. | Biomedicines | 2022 | 35884795 | PubTator, text mining | PubMed |
| High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential. | Int J Biol Sci | 2022 | 35864955 | PubTator, text mining | PubMed |
| Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases. | Aging Dis | 2022 | 35855336 | PubTator, text mining | PubMed |
| Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases. | Front Cell Neurosci | 2022 | 35846567 | PubTator, text mining | PubMed |
| DNA repair as a shared hallmark in cancer and ageing. | Mol Oncol | 2022 | 35834102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=25